180 Wealth Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-545
| Closed | -$6.98K | – | 451 |
|
|
2024
Q2 | $6.98K | Sell |
545
-96
| -15% | -$1.23K | ﹤0.01% | 434 |
|
|
2024
Q1 | $29.7K | Buy |
641
+4
| +0.6% | +$186 | 0.01% | 402 |
|
|
2023
Q4 | $42.6K | Sell |
637
-42
| -6% | -$2.81K | 0.01% | 380 |
|
|
2023
Q3 | $49.2K | Buy |
679
+5
| +0.7% | +$362 | 0.01% | 368 |
|
|
2023
Q2 | $48K | Sell |
674
-68
| -9% | -$4.84K | 0.01% | 362 |
|
|
2023
Q1 | $39.5K | Hold |
742
| – | – | 0.01% | 362 |
|
|
2022
Q4 | $51.9K | Buy |
742
+28
| +4% | +$1.96K | 0.01% | 363 |
|
|
2022
Q3 | $89K | Sell |
714
-38
| -5% | -$4.74K | 0.02% | 344 |
|
|
2022
Q2 | $72K | Buy |
752
+93
| +14% | +$8.9K | 0.02% | 359 |
|
|
2022
Q1 | $101K | Buy |
659
+343
| +109% | +$52.6K | 0.02% | 365 |
|
|
2021
Q4 | $67K | Buy |
+316
| New | +$67K | 0.02% | 368 |
|